NYSE:ALB - Albemarle Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $66.34 -1.62 (-2.38 %) (As of 05/24/2019 06:48 AM ET)Previous Close$67.96Today's Range$65.98 - $67.2252-Week Range$67.06 - $108.74Volume2.14 million shsAverage Volume1.89 million shsMarket Capitalization$7.03 billionP/E Ratio12.11Dividend Yield2.15%Beta1.56 ProfileAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The company's Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. Its Catalysts segment offers performance catalyst solutions comprising hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. The company was founded in 1994 and is headquartered in Charlotte, North Carolina. Receive ALB News and Ratings via Email Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Plastics materials & resins Sub-IndustrySpecialty Chemicals SectorBasic Materials Current SymbolNYSE:ALB Previous Symbol CUSIP01265310 CIK915913 Webhttp://www.albemarle.com/ Phone980-299-5700Debt Debt-to-Equity Ratio0.36 Current Ratio1.55 Quick Ratio0.96Price-To-Earnings Trailing P/E Ratio12.11 Forward P/E Ratio10.63 P/E Growth0.71 Sales & Book Value Annual Sales$3.37 billion Price / Sales2.08 Cash Flow$7.3062 per share Price / Cash Flow9.08 Book Value$36.47 per share Price / Book1.82Profitability EPS (Most Recent Fiscal Year)$5.48 Net Income$693.56 million Net Margins20.54% Return on Equity15.53% Return on Assets7.72%Miscellaneous Employees5,900 Outstanding Shares105,960,000Market Cap$7.03 billion Next Earnings Date8/6/2019 (Estimated) OptionableOptionable Albemarle (NYSE:ALB) Frequently Asked Questions What is Albemarle's stock symbol? Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB." How often does Albemarle pay dividends? What is the dividend yield for Albemarle? Albemarle declared a quarterly dividend on Wednesday, May 8th. Investors of record on Friday, June 14th will be paid a dividend of $0.3675 per share on Monday, July 1st. This represents a $1.47 annualized dividend and a dividend yield of 2.22%. The ex-dividend date is Thursday, June 13th. View Albemarle's Dividend History. How were Albemarle's earnings last quarter? Albemarle Co. (NYSE:ALB) announced its quarterly earnings data on Wednesday, May, 8th. The specialty chemicals company reported $1.23 EPS for the quarter, topping the consensus estimate of $1.21 by $0.02. The specialty chemicals company had revenue of $832.06 million for the quarter, compared to the consensus estimate of $827.94 million. Albemarle had a return on equity of 15.53% and a net margin of 20.54%. The business's revenue was up 1.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.30 earnings per share. View Albemarle's Earnings History. When is Albemarle's next earnings date? Albemarle is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Albemarle. What guidance has Albemarle issued on next quarter's earnings? Albemarle issued an update on its FY19 earnings guidance on Wednesday, May, 8th. The company provided earnings per share guidance of $6.10 to $6.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.20. The company issued revenue guidance of $3.65 billion to $3.85 billion, compared to the consensus revenue estimate of $3.68 billion.Albemarle also updated its FY 2019 guidance to $6.10-6.50 EPS. What price target have analysts set for ALB? 15 equities research analysts have issued 12 month price objectives for Albemarle's shares. Their forecasts range from $59.00 to $125.00. On average, they expect Albemarle's stock price to reach $95.7740 in the next twelve months. This suggests a possible upside of 44.4% from the stock's current price. View Analyst Price Targets for Albemarle. What is the consensus analysts' recommendation for Albemarle? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Albemarle. Has Albemarle been receiving favorable news coverage? Press coverage about ALB stock has trended negative on Friday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Albemarle earned a daily sentiment score of -2.7 on InfoTrie's scale. They also assigned media coverage about the specialty chemicals company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the near future. Who are some of Albemarle's key competitors? Some companies that are related to Albemarle include Eastman Chemical (EMN), Hexcel (HXL), Sinopec Shanghai Petrochemical (SHI), Rogers (ROG), PolyOne (POL), Trinseo (TSE), Kraton (KRA), AdvanSix (ASIX), A Schulman (SHLM), Cereplast (CERPQ) and ForceField Energy (FNRG). What other stocks do shareholders of Albemarle own? Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Rogers Communications (RCI), Open Text (OTEX) and Valeant Pharmaceuticals Intl (VRX). Who are Albemarle's key executives? Albemarle's management team includes the folowing people: Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 54)Mr. Scott A. Tozier, Exec. VP & CFO (Age 53)Mr. Donald J. LaBauve Jr., VP, Corp. Controller & Chief Accounting Officer (Age 52)Ms. Karen G. Narwold, Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 59)Mr. David Ryan, VP of Corp. Strategy & Investor Relations Who are Albemarle's major shareholders? Albemarle's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.20%), Primecap Management Co. CA (4.17%), Baillie Gifford & Co. (2.49%), Principal Financial Group Inc. (1.62%), Dimensional Fund Advisors LP (1.41%) and Artisan Partners Limited Partnership (1.39%). Company insiders that own Albemarle stock include Deeanne J Marlow, Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle. Which institutional investors are selling Albemarle stock? ALB stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Iridian Asset Management LLC CT, Federated Investors Inc. PA, CIBC Private Wealth Group LLC, Marshall Wace LLP, Wells Fargo & Company MN, SEI Investments Co and SG Americas Securities LLC. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Scott Tozier. View Insider Buying and Selling for Albemarle. Which institutional investors are buying Albemarle stock? ALB stock was bought by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Dimensional Fund Advisors LP, Primecap Management Co. CA, Artisan Partners Limited Partnership, BlackRock Inc., Oxford Asset Management LLP, US Bancorp DE and Janney Capital Management LLC. View Insider Buying and Selling for Albemarle. How do I buy shares of Albemarle? Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Albemarle's stock price today? One share of ALB stock can currently be purchased for approximately $66.34. How big of a company is Albemarle? Albemarle has a market capitalization of $7.03 billion and generates $3.37 billion in revenue each year. The specialty chemicals company earns $693.56 million in net income (profit) each year or $5.48 on an earnings per share basis. Albemarle employs 5,900 workers across the globe. What is Albemarle's official website? The official website for Albemarle is http://www.albemarle.com/. How can I contact Albemarle? Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected] MarketBeat Community Rating for Albemarle (NYSE ALB)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 614 (Vote Outperform)Underperform Votes: 494 (Vote Underperform)Total Votes: 1,108MarketBeat's community ratings are surveys of what our community members think about Albemarle and other stocks. Vote "Outperform" if you believe ALB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: What are no-load funds? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.